The increasing prevalence of neoplasias is associated with new clinical challenges, one of which is acute kidney injury (AKI). In addition to possibly constituting a clinical emergency, kidney failure ...
The FDA approved the CD38-targeting mAb daratumumab and hyaluronidase (Darzalex Faspro; Janssen) in combination with the protease inhibitor bortezomib, the immunomodulatory drug lenalidomide, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results